Clinical Trial Update: PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing PegIntron (pegylated interferon alfa-2b) versus Adefovir in HBeAg-positive chronic hepatitis B patients in Taiwan; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepsera (adefovir dipivoxil)
• PegIntron (pegylated interferon alfa-2b)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis B, Chronic (CHB) | Phase 3 | Status: COMPLETED | Results posted: 2010-12-15